After two straight days of sell-offs, the major indexes waffled on Wall Street Tuesday. Axios Business Editor Dan Primack explains the factors potentially driving this market volatility. Disney stock rose after they beat on earnings per share. Chipotle also reported and beat on both revenue and earnings per share. Cheddar breaks down the earnings reports from both companies. Snap beat on both revenue and earnings per share, marking one of its best earning reports to date. In after hours, Snap shares rocketed up as user growth was reported as an increase. Recreational marijuana has been legal in California since January 1 and since then cannabis stores like MedMen in West Hollywood have been a significant bump in sales and foot traffic. Alyssa Julya Smith visited the MedMen location in West Hollywood one month after the store first started selling recreational marijuana.

Share:
More In Business
Poll: More Americans think companies benefit from legal immigration
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Tylenol maker rebounds a day after unfounded claims about its safety
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
Load More